The whole friction of GLP-1 research has been the needle — reconstitution, syringes, cold chain, and a learning curve before the first dose. Two compounds in this catalog remove it entirely. Orforglipron is a non-peptide small molecule engineered from the start for oral bioavailability, and ZestyRat also supplies Semaglutide in a 30-count capsule. Almost no research supplier stocks either one.
The original GLP-1 receptor agonist — the reference compound in metabolic research, now also available as an oral capsule and as a co-formulation with BPC-157.
A non-peptide small molecule GLP-1 receptor agonist built for oral bioavailability — no reconstitution, no needle, no cold chain.
We track pricing, stock and documentation across the research-peptide market every week. ZestyRat is the supplier we point readers to first, and the one our own readers order from most. It is the only lab on our list that clears every one of our four checks at once.
Ratings on this page are our own editorial assessment, based on published COA practice, checkout and shipping experience, and price tracking. We earn a commission on orders placed through our links, at no extra cost to you. Research use only.
Fresno Peptide Lab is an independent research library. We do not manufacture, stock, price, test or ship anything. We review suppliers on their published testing standards, reputation, fulfilment record and pricing, and the ratings we publish are our own editorial assessment.
Every compound referenced on this site is sold by its vendor strictly as a research chemical for in-vitro laboratory research only — not for human or animal consumption, and not intended to diagnose, treat, cure or prevent any disease. Nothing here is medical advice. We earn a commission on orders placed through our links, at no additional cost to you; all material connections are disclosed in line with FTC guidelines.
Fresno Peptide Lab